PMA device
Zilver Vena Venous Self-Expanding Stent
Cook Ireland, Ltd. · Stent, Iliac Vein (QAN, Class III) · First FDA decision Oct 9, 2020, newest Feb 8, 2024Pulmonary embolism and deep vein thrombosisVaricose veins and venous insufficiency
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
3
Naming "Zilver Vena Venous"
MAUDE reports
258
Brand "Zilver Vena Venous", since 2015
PubMed studies
9
Mentioning "Zilver Vena Venous"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Zilver Vena Venous Self-Expanding Stent
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Zilver Vena Venous Self-Expanding StentPMA supplement
P200023-S007 · Decided Feb 8, 2024 · 104 days after receipt · Normal 180 Day Track
Device type: Stent, iliac vein (QAN) · Cardiology
P200023 · Decided Oct 9, 2020 · 179 days after receipt
Device type: Stent, iliac vein (QAN) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Zilver Vena Venous", any status and sponsor, newest update first.
- Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or OcclusionPivotal-lookingCompleted
Zhejiang Zylox Medical Device Co., Ltd.Not on our public-company list
NCT04812444 · 220 participants · Start Oct 9, 2020 · Primary completion Oct 20, 2023
Device: Zylox Peripheral Venous Stent; Zilver Vena Venous Stent · For: Iliac Vein Stenosis; Iliac Vein Occlusion
Sites: Chongqing, China
- VIVO Clinical StudyCompleted
Cook Research IncorporatedNot on our public-company list
NCT01970007 · 243 participants · Start Dec 13, 2013 · Primary completion Nov 20, 2017
Device: Zilver Vena Venous Self-Expanding Stent · For: Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein
Sites: Birmingham, Alabama; Glendale, Arizona; Littleton, Colorado · 30 sites in all
Cook Group IncorporatedNot on our public-company list
NCT01663051 · 35 participants · Start Nov 2012 · Primary completion Jul 2016
Device: Zilver Vena Venous Stent · For: Iliofemoral Venous Outflow Obstruction
Sites: Arnsberg, Germany; Galway, Ireland; Madrid, Spain · 5 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Zilver Vena Venous", and for the whole product code for context.
This brand
258 reports: 91 malfunction, 167 injury, 0 death
Whole product code QAN
1,334 reports: 763 malfunction, 563 injury, 8 death
Newest reports for this brand
- Zilver Vena venous stentMalfunction
3001845648-2026-00366 · Received Sep 14, 2026
Device type: Stent, Iliac Vein (QAN)
Device problem as coded: Deformation Due to Compressive Stress
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Zilver Vena venous stentInjury
3001845648-2026-00322 · Received Aug 11, 2026 · Event dated Feb 19, 2026
Device type: Stent, Iliac Vein (QAN)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Obstruction/Occlusion
3001845648-2026-00066 · Received Mar 3, 2026
Device type: Stent, Iliac Vein (QAN)
Device problem as coded: Off-Label Use
Patient problem as coded: Foreign Body In Patient
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Zilver Vena Venous"[tiab]. The summary above synthesizes these.
- Real-world outcomes of Zilver Vena® Venous Self Expanding Stent placement for thrombotic and non-thrombotic indications in Spain.
Ramirez Ortega M, Tejero OT, Benages EM, et al. · Phlebology · 2025
- Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study).
Hofmann LR, Gagne P, Brown JA, et al. · J Vasc Surg Venous Lymphat Disord · 2023Clinical Trial, Multicenter Study
- Final 3-Year Study Outcomes from the Evaluation of the Zilver Vena Venous Stent for the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction (The VIVO Clinical Study).
Comerota AJ, Gagne P, Brown JA, et al. · J Vasc Interv Radiol · 2024Multicenter Study, Research Support, Non-U.S. Gov't
- Venous Stents: Current Status and Future Directions.
Shamimi-Noori SM, Clark TWI · Tech Vasc Interv Radiol · 2018Review
- One Year Outcomes of the VIVO-EU Study of Treatment of Symptomatic Iliofemoral Outflow Obstruction with the Zilver Vena Venous Self-Expanding Stent.
O'Sullivan GJ, Karunanithy N, Binkert CA, et al. · Cardiovasc Intervent Radiol · 2021Multicenter Study
- Comparison of the Zylox Penguin Venous Stent System and Zilver Vena Stent for Non-thrombotic Iliac Vein Lesions: A Multicentre Randomised Controlled Trial.
Liu H, Zeng Q, Li F, et al. · Eur J Vasc Endovasc Surg · 2026
- Another Venous Stent Design - Or Not?
Bækgaard N, Jalaie H · Eur J Vasc Endovasc Surg · 2026
- A Retrospective Multicenter Clinical Trial of Venastent for Patients with Iliac Vein Compression Syndrome.
Chen K, Zhu J, Wang WB, et al. · Ann Vasc Surg · 2026Multicenter Study
- May-Thurner syndrome, a diagnosis to consider in young males with no risk factors: a case report and review of the literature.
Hng J, Su S, Atkinson N · J Med Case Rep · 2021Case Reports, Review
Other devices of this type
Also filed under product code QAN.
- VICI VENOUS STENT SystemBoston Scientific Corporation · PMA 2021
- Duo Venous Stent SystemPhilips Image Guided Therapy Corporation · PMA 2026
- Abre Venous Self-expanding Stent SystemMedtronic Vascular, Inc. · PMA 2022
- Venovo Venous Stent SystemBard Peripheral Vascular, Inc. · PMA 2021
- Venous WallstentBoston Scientific Corporation · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.